Category: Uncategorized

NAD+ precursor supplements promise anti-aging benefits, yet their effects on prostate cancer may be more complex than expected. While boosting NAD+ can support cellular wellness, research suggests it might also help cancer cells thrive. Get balanced insights from recent studies. keep reading

A recent trial comparing MRI-guided biopsy to MRI plus PSMA PET/CT for prostate cancer found no significant difference in detecting clinically significant cancers. While combining imaging may reveal slightly more lesions, the benefit appears minimal and doesn’t outweigh added costs or complexity. keep reading

What if treating prostate cancer didn’t have to mean sacrificing the whole gland? Thanks to advances in multiparametric MRI and MRI-targeted biopsy, focal therapy can pinpoint and erase tumors with a margin of safety while sparing healthy tissue. Lower side effect rates and preserved function set this approach apart. keep reading

The word malignant comes from malignare, a Latin verb that means to intend to do evil. The ultimate evil is death. A cancerous tumor is called a malignancy because it causes death. As kids, cartoons and comic books show that evil villains are out to destroy the good guys, but there are either a) clever keep reading

The search for a prostate cancer (PCa) cure involves general practitioners, internal medicine doctors, surgeons, radiologists, oncologists, and biologists—to name just a few. It may surprise you to learn that your personal trainer or coach may also have something to offer in terms of defeating PCa and other tumor cancers: exercise! As surprising as it keep reading

History is littered with poor judgments, often on the part of a very small handful of people—or even a single individual. If you’re a trivia buff, you’d recognize the name of J. Bruce Ismay, owner of the Titanic, who determined a mere 20 lifeboats would be enough for an unsinkable ship. Or how about Willem keep reading

These days, Active Surveillance (AS) seems to be the new best friend for prostate cancer (PCa) patients. Over 40% of newly diagnosed, low-to-favorable intermediate risk patients now begin PCa management on AS. This method defers treatment, but there’s a catch. Patients must be responsible to: Obtain the most thorough portrait of your PCa (multiparametric MRI, keep reading

I was very interested in a new study about cancer survivors and the need for exercise. The article I found in the Journal of the American Medical Association (JAMA) applies just as much to prostate cancer (PCa) survivors as any other cancer—and that includes our patients whose focal disease was treated with Focal Laser Ablation keep reading

The question posed in the title is a worthy one, given the increasing attraction of applying Artificial Intelligence (AI) to medicine, specifically in detecting and diagnosing prostate cancer (PCa). Why do we need this? Is there something lacking in the way doctors have been performing? Well, not exactly. Radiologists and urologists who are experienced in keep reading